Streetbeat News

Earnings

CSX

CSX Corporation reported weaker-than-expected Q3 earnings, missing both earnings per share and revenue estimates. Analysts have subsequently lowered their price targets for the stock.

Portfolio Pulse from Avi Kapoor

October 17, 2024 | 1:08 pm

SOXX

TSM

September retail sales exceeded expectations, indicating strong consumer spending and positive economic growth. Jobless claims fell more than expected, further boosting market confidence. Semiconductor stocks, led by Taiwan Semiconductor Manufacturing Company (TSMC), surged, driving up the S&P 500 and Nasdaq 100 futures. The iShares Semiconductor ETF (SOXX) also rose significantly.

Portfolio Pulse from Piero Cingari

October 17, 2024 | 1:02 pm

WIT

Wipro Ltd (NYSE:WIT) reported a 2% decline in IT Services revenue for Q2, with gross revenue slightly below analyst expectations. Despite a 21.3% increase in net income, the stock slid due to the revenue miss. The company proposed a 1:1 stock bonus, subject to shareholder approval.

Portfolio Pulse from Anusuya Lahiri

October 17, 2024 | 12:57 pm

VABK

Virginia National Bankshares reported a slight decrease in Q3 earnings per share, down to $0.85 from $0.86 year-over-year.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:55 pm

BAH

DEA

OKE

TDG

On CNBC's 'Halftime Report Final Trades,' analysts discussed TransDigm, Easterly Government Properties, Booz Allen Hamilton, and ONEOK. TransDigm's price target was raised by JPMorgan, Easterly Government Properties was upgraded by Jefferies, Booz Allen Hamilton's price target was increased by Goldman Sachs, and ONEOK's price target was raised by RBC Capital.

Portfolio Pulse from Avi Kapoor

October 17, 2024 | 12:54 pm

INFY

Infosys shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:50 pm

ABBV

ABT

CLOV

CORZ

GXO

ORCL

SG

Jim Cramer expressed his preference for Abbott Laboratories over AbbVie, despite AbbVie's strong performance. UBS raised AbbVie's price target. Oracle's data center business is praised, and Core Scientific is likened to Palantir. Clover Health's Medicare plans received a higher Star rating. GXO Logistics is valued for its new partnership, and Sweetgreen is anticipated to release its Q3 results.

Portfolio Pulse from Avi Kapoor

October 17, 2024 | 12:49 pm

MIGI

Mawson Infrastructure Group reported a 65% YoY increase in revenue for September 2024, reaching $4.15M. The company saw significant growth in its energy management and digital colocation businesses. Mawson completed Phase 1 construction at its Ohio facility, aiming to boost capacity to 153 MW.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:49 pm

IAK

KBWP

TRV

The Travelers Companies (NYSE:TRV) reported a strong Q3 with a 12% revenue growth to $11.904 billion, surpassing expectations. Core income per share rose 169% to $5.24, driven by underwriting gains and investment income. The company declared a $1.05 dividend and returned $496 million to shareholders. TRV shares rose 4.96% premarket.

Portfolio Pulse from Lekha Gupta

October 17, 2024 | 12:45 pm

MAN

ManpowerGroup's shares are declining as the company released Q4 EPS guidance that falls short of market expectations.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 12:45 pm